The incidence and influencing factors of hypertensive disorders during pregnancy in hangzhou, China, between 2012 and 2021

2012年至2021年中国杭州市妊娠期高血压疾病的发生率及其影响因素

阅读:2

Abstract

OBJECTIVE: To analyze the incidence and influencing factors of hypertensive disorders of pregnancy (HDP) in Hangzhou, China, between 2012 and 2021. METHODS: We conducted a retrospective cohort study to analyze data relating to 155,433 pregnant women in Hangzhou, China, who were divided into eight groups: gestational hypertension (GH, 4247 cases), preeclampsia (PE, 1602 cases), severe preeclampsia (SPE, 995 cases), eclampsia (9 cases), HELLP syndrome (43 cases), chronic hypertension (43 cases), chronic hypertension combined with PE or SPE (77 cases), postpartum eclampsia (5 cases), and pregnant women with normal blood pressure (148412 cases). Odds ratios (ORs) and 95 % confidence intervals (95 % CIs) were used to show the association of factors with HDP. RESULTS: The total incidence of HDP was 45.17 ‰ (95 % CI: 44.14‰-46.20 ‰), and the subtypes of HDP showed an increasing trend from 2012 to 2021 (all P < 0.01). Several maternal characteristics, including maternal age (OR(GH) = 1.158 (1.035-1.295), 1.697 (1.478-1.948), and 2.769 (2.234-3.433), OR(PE) = 1.526 (1.224-1.902) to 2.506 (1.796-3.497)), non-local residence (OR = 1.124 (1.018-1.241), 1.212 (1.032-1.423), and 1.222 (1.010-1.479)), in vitro fertilization (OR = 1.263 (1.028-1.551), 1.342 (1.042-1.729) and 1.692 (1.234-2.321)), graviditas ≤1 (OR(GH) = 1.126 (1.035-1.226)), parity <1 (OR(GH) = 1.140 (1.026-1.265), OR(PE) = 1.336 (1.130-1.581)), non-vaginal delivery (OR(GH) = 1.525 (1.223-1.901), 1.185 (1.058-1.328) an 1.753 (1.612-1.908); OR(pe) = 2.108 (1.428-3.112), 1.464 (1.174-1.826) and 4.205 (3.643-4.854), and OR(spe) = 7.000 (3.517-13.930), 1.914 (1.217-3.010) and 19.981 (14.936-26.730)), maternal hospitalization >7 days (OR = 2.098 (1.921-2.291), 2.115 (1.857-2.409), and 1.553 (1.333-1.810)), and winter birth (OR(GH) = 1.297 (1.196-1.408), OR(PE) = 1.425 (1.242-1.636)), were all identified as risk factors for GH, PE, and SPE. Furthermore, HDP may increase the risk of gestational period <37 weeks, low birth weight (LBW), fetal macrosomia, and a birth length <50 cm (all P < 0.05). CONCLUSIONS: The incidence of HDP and its subtypes showed an overall increasing trend from 2012 to 2021. Maternal factors and pregnancy outcomes may be strongly associated with HDP.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。